New study unveils the impact of MXene quantum dots on tumor and immune cells as nanoparticles offer new hope in the fight against cancer
In a significant leap forward for cancer nanomedicine, a groundbreaking study has revealed how MXene quantum dots (MQDs) interact with tumors and their surrounding environments to influence cancer treatment outcomes.
Khalifa University’s Dr. Lucia Gemma Delogu led an international group of scientists from Ankara University, Turkey; University of Manitoba, Canada; Drexel University, USA; Gazi University, Turkey; and the International Agency for Research on Cancer, World Health Organization. Their research was published in, a top 1% journal. Their research Ðǿմ«Ã½ the potential of MQDs to enhance cancer therapy through their interactions with immune cells and tumor microenvironments (TMEs).
Nanoparticles have become a cornerstone of modern cancer therapy, known for their ability to overcome the limitations of traditional treatments. However, the complex and heterogeneous nature of tumors presents ongoing challenges. A TME is a dynamic ecosystem, comprising cancer cells and a diverse array of immune cells that can significantly affect the efficacy of treatments. Understanding how nanoparticles interact with these various cell types is crucial for developing more effective therapies.
The research team explored the use of a particular bidimensional material: MXene quantum dots. Their small size and fluorescent properties made them ideal for tracking and studying their distribution with tumors. The researchers used spatial transcriptomics, an advanced technique combining histology and sequencing, to map the gene expression and cellular interactions within the tumor microenvironment. By injecting MQDs into breast cancer tumors in mice, they tracked how these nanoparticles distributed themselves within the tumor and influenced various cell population reactions.
In regions where MQDs accumulated in high concentrations, a notable tumor-suppressive effect was observed. These areas showed increased apoptosis (programmed cell death) and decreased proliferation of tumor cells. Gene expression analysis indicated significant downregulation of pathways involved in cell survival and a process often linked to cancer metastasis.
Conversely, in regions with low MQD accumulation, a more protumorigenic profile was seen, meaning that the cellular and molecular environment in these regions was conducive to tumor growth and survival, rather than suppression. This Ðǿմ«Ã½ the importance of ensuring adequate distribution of nanoparticles within the tumor to achieve the desired therapeutic effect of inhibiting tumor growth.
The researchers found that B cells and plasma cells were key players in high-MQD regions. These immune cells were activated in response to MQD accumulation, suggesting that MQDs can modulate the immune landscape within the tumor. This activation could potentially enhance the body’s natural immune response against cancer cells.
ÌýUsing spatial transcriptomic provided detailed insights into the molecular and cellular dynamics at play, paving the way for more targeted and effective nanomedicine strategies. Further research will need to explore various MXenes and cancer types to fully understand the complex interactions within the TME.
Ìý
Jade Sterling
Science Writer
22 July 2024